Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
The Journal of Antibiotics, doi:10.1038/s41429-020-0336-z
Ivermectin proposes many potentials effects to treat a range of diseases, with its antimicrobial, antiviral, and anti-cancer properties as a wonder drug. It is highly effective against many microorganisms including some viruses. In this comprehensive systematic review, antiviral effects of ivermectin are summarized including in vitro and in vivo studies over the past 50 years. Several studies reported antiviral effects of ivermectin on RNA viruses such as Zika, dengue, yellow fever, West Nile, Hendra, Newcastle, Venezuelan equine encephalitis, chikungunya, Semliki Forest, Sindbis, Avian influenza A, Porcine Reproductive and Respiratory Syndrome, Human immunodeficiency virus type 1, and severe acute respiratory syndrome coronavirus 2. Furthermore, there are some studies showing antiviral effects of ivermectin against DNA viruses such as Equine herpes type 1, BK polyomavirus, pseudorabies, porcine circovirus 2, and bovine herpesvirus 1. Ivermectin plays a role in several biological mechanisms, therefore it could serve as a potential candidate in the treatment of a wide range of viruses including COVID-19 as well as other types of positive-sense single-stranded RNA viruses. In vivo studies of animal models revealed a broad range of antiviral effects of ivermectin, however, clinical trials are necessary to appraise the potential efficacy of ivermectin in clinical setting.
Conflict of interest The authors declare that they have no conflict of interest. Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Ang, Lee, Choi, Zhang, Lee, Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines, Integr Med Res, doi:10.1016/j.imr.2020.100407.
Atkinson, Audsley, Lieu, Recognition by host nuclear transport proteins drives disorder-to-order transition in Hendra virus V, Sci Rep, doi:10.1038/s41598-017-18742-8
Azeem, Ashraf, Rasheed, Anjum, Hameed, Evaluation of cytotoxicity and antiviral activity of ivermectin against Newcastle disease virus, Pak J Pharm Sci
Bennett, Zhao, Bosard, Imperiale, Role of a nuclear localization signal on the minor capsid proteins VP2 and VP3 in BKPyV nuclear entry, Virology, doi:10.1016/j.virol.2014.10.013.
Berthomme, Monahan, Parris, Jacquemont, Epstein, Cloning, sequencing, and functional characterization of the two subunits of the pseudorabies virus DNA polymerase holoenzyme: evidence for specificity of interaction, J Virol
Canga, Prieto, Liébana, Martínez, Vega et al., The pharmacokinetics and interactions of ivermectin in humans-a mini-review, AAPS J
Croci, Bottaro, Chan, Liposomal systems as nanocarriers for the antiviral agent ivermectin, Int J Biomater, doi:10.1155/2016/8043983.
Crump, Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations, J Antibiot
Crump, Ōmura, Ivermectin, 'wonder drug' from Japan: the human use perspective, Proc Jpn Acad Ser B Phys Biol Sci, doi:10.2183/pjab.87.13
Fraser, Rawlinson, Wang, Jans, Wagstaff, Investigating dengue virus nonstructural protein 5 (NS5) nuclear import, Methods Mol Biol, doi:10.1007/978-1-4939-0348-1_19.
Ge, Li, Yang, Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor, Nature, doi:10.1038/nature12711.
Gharebaghi, Heidary, Moradi, Parvizi, Metronidazole; a potential novel addition to the COVID-19 treatment regimen, Arch Academic Emerg Med
Gonzalez Canga, Prieto, Liebana, Martinez, Vega et al., The pharmacokinetics and interactions of ivermectin in humans-a mini-review, AAPS J, doi:10.1208/s12248-007-9000-9.
Gotz, Magar, Dornfeld, Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import, Sci Rep, doi:10.1038/srep23138.
Ji, Luo, Zika virus NS5 nuclear accumulation is protective of protein degradation and is required for viral RNA replication, Virology, doi:10.1016/j.virol.2019.10.010.
Ketkar, Yang, Wormser, Wang, Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system, Diagn Microbiol Infect Dis, doi:10.1016/j.diagmicrobio.2019.03.012.
Khalil, Samrah, In vivo combined treatment of rats with ivermectin and aged garlic extract attenuates ivermectininduced cytogenotoxicity in bone marrow cells, Res Vet Sci, doi:10.1016/j.rvsc.2018.09.005.
Kircik, Rosso, Layton, Schauber, Over 25 years of clinical experience with ivermectin: an overview of safety for an increasing number of indications, J Drugs Dermatol
Kosyna, Nagel, Kluxen, Kraushaar, Depping, The importin alpha/beta-specific inhibitor Ivermectin affects HIFdependent hypoxia response pathways, Biol Chem, doi:10.1515/hsz-2015-0171.
Lee, Lee, Ivermectin inhibits porcine reproductive and respiratory syndrome virus in cultured porcine alveolar macrophages, Arch Virol, doi:10.1007/s00705-015-2653-2.
Lu, Stratton, Tang, Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle, J Med Virol, doi:10.1002/jmv.25678.
Lundberg, Pinkham, Baer, Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan equine encephalitis virus replication, Antivir Res, doi:10.1016/j.antiviral.2013.10.004.
Lv, Liu, Wang, Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo, Antivir Res, doi:10.1016/j.antiviral.2018.09.010.
Mastrangelo, Pezzullo, Burghgraeve, Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug, J Antimicrob Chemother, doi:10.1093/jac/dks147.
Raza, Zhai, Ivermectin inhibits bovine herpesvirus 1 DNA polymerase nuclear import and interferes with viral replication, Microorganisms, doi:10.3390/microorganisms8030409
Reviglio, Osaba, Reviglio, Chiaradia, Kuo, COVID-19 and ophthalmology: a new chapter in an old story, Med Hypothesis Disco Innov Ophthalmol
Shechter, Thomas, Lundberg, Novel inhibitors targeting Venezuelan equine encephalitis virus capsid protein identified using in silico structure-based-drug-design, Sci Rep, doi:10.1038/s41598-017-17672-9.
Slonska, Cymerys, Skwarska, Golke, Banbura, Influence of importin alpha/beta and exportin 1 on equine herpesvirus type 1 (EHV-1) replication in primary murine neurons, Pol J Vet Sci, doi:10.2478/pjvs-2013-0106.
Sohrabi, Alsafi, Neill, World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19), Int J Surg, doi:10.1016/j.ijsu.2020.02.034.
Tay, Fraser, Chan, Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin, Antivir Res, doi:10.1016/j.antiviral.2013.06.002.
Varghese, Kaukinen, Glasker, Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses, Antivir Res, doi:10.1016/j.antiviral.2015.12.012.
Wagstaff, Rawlinson, Hearps, Jans, An AlphaScreen(R)-based assay for high-throughput screening for specific inhibitors of nuclear import, J Biomol Screen, doi:10.1177/1087057110390360.
Wagstaff, Sivakumaran, Heaton, Harrich, Jans, Ivermectin is a specific inhibitor of importin alpha/beta-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus, Biochem J, doi:10.1042/BJ20120150.
Wang, Du, Huang, The pseudorabies virus DNA polymerase accessory subunit UL42 directs nuclear transport of the holoenzyme, Front Microbiol, doi:10.3389/fmicb.2016.00124.
Wang, Lv, Wang, Qiu, Yang, Ivermectin treatment inhibits the replication of Porcine circovirus 2 (PCV2) in vitro and mitigates the impact of viral infection in piglets, Virus Res, doi:10.1016/j.virusres.2019.01.010.
Yang, Atkinson, Wang, The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta1 heterodimer, Antivir Res, doi:10.1016/j.antiviral.2020.104760.
Yang, Hu, Wang, Isolation and characterization of a novel bat coronavirus closely related to the direct progenitor of severe acute respiratory syndrome coronavirus, J Virol, doi:10.1128/JVI.02582-15.